Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
28 nov. 2018 08h30 HE
|
Resverlogix Corp
CALGARY, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone...